glp 1 going gray Q&A: GLP-1 medications MindRank raises $52m to advance

Better Blood Sugar Control GLP-1 stimulates insulin secretion in a glucose-dependent manner, lowers glucagon output, and improves insulin sensitivity, all helping reduce blood sugar

Additionally, ongoing studies suggest that GLP-1 medications may benefit conditions such as non-alcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS) by improving insulin sensitivity, reducing inflammation, and positively influencing metabolism

Thankfully, both issues can be avoided with the right approach

GLP-1 (glucagon-like peptide-1) receptor agonists work by helping regulate appetite, slow digestion, and support blood sugar balance

Energy, metabolism, cognitive function & vitality